The Saudi Journal of Medical Insights

21st-century healthcare landscape is dominated by the escalating burden of chronic diseases, creating a pressing need for therapeutic strategies that bridge the gap between lifelong pharmacotherapy and radical surgery. This review explores the paradigm of therapeutic minimal invasive injury, a novel approach that employs controlled, localized insults to trigger beneficial systemic responses for chronic disease management. Moving beyond symptomatic management, these procedures—such as renal denervation for hypertension, endoscopic sleeve gastroplasty for obesity, and duodenal mucosal resurfacing for type 2 diabetes—leverage the body's innate healing mechanisms to reset maladaptive physiological pathways. We examine the robust clinical evidence supporting the efficacy of these interventions across cardiovascular, metabolic, and oncologic diseases, highlighting their role in achieving durable disease modification, reducing morbidity, and improving quality of life. The mechanisms underpinning this approach, including immunomodulation, neuro-hormonal reprogramming, and the attenuation of systemic stress, are dissected to elucidate the link between localized injury and global therapeutic benefit. Finally, the review addresses the challenges and future directions of this rapidly evolving field, concluding that therapeutic minimal invasive injury represents a fundamental shift towards recalibrating physiological set points, offering a potent and often superior alternative to conventional chronic disease management.